Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03572634
Title Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Tolero Pharmaceuticals, Inc.
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Arizona Phoenix Arizona 85054 United States Details
Mayo Clinic Florida Jacksonville Florida 32224 United States Details
Mayo Clinic Rochester Rochester Minnesota 55905 United States Details
Washington University - St Louis Saint Louis Missouri 63130 United States Details
Cornell University New York New York 10065 United States Details
Duke University Durham North Carolina 27705 United States Details
*Shaded cells indicate that there was no data available from for the field